Skip to main content

Sodium Acetate Injection Shortage

Last Updated: April 11, 2024
Status: Current

Products Affected - Description
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 100 mL vial, 25 count, NDC 00409-3299-06
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-7299-73
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3299-05
Reason for the Shortage
    • Fresenius Kabi has sodium acetate injection available
    • Pfizer has sodium acetate injection on shortage due to manufacturing delays.
    • Woodward Pharma has sodium acetate injection available.
Available Products
    • Sodium acetate injection, Fresenius Kabi, 4 mEq/mL, 100 mL vial, 20 count, NDC 63323-0032-00
    • Sodium acetate injection, Woodward, 2 mEq/mL, 100 mL vial, 10 count, NDC 69784-0231-10
    • Sodium acetate injection, Woodward, 2 mEq/mL, 50 mL vial, 10 count, NDC 69784-0230-10
    • Sodium acetate injection, Woodward, 4 mEq/mL, 100 mL vial, 10 count, NDC 69784-0232-01

Estimated Resupply Dates

    • Pfizer has sodium acetate 2 mEq/mL 20 mL vials on back order and the company estimates a release date of June 2024. The 50 mL and 100 mL vials are only available for emergency orders via direct orders.

Updated

Updated April 11, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 1, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.